Behavioral Health Exam 2: Neurobiologic Theories, Psychopharmacology, and Legal Issues

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/36

flashcard set

Earn XP

Description and Tags

Flashcards covering neurobiologic theories, psychopharmacology, legal/ethical issues, aggression management, and trauma-related disorders as outlined in the Behavior Health Exam 2 Blueprint.

Last updated 5:00 PM on 6/12/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

37 Terms

1
New cards

GABA

An inhibitory neurotransmitter that modulates other neurotransmitters; drugs like benzodiazepines increase it to treat anxiety and induce sleep.

2
New cards

Serotonin

An inhibitory neurotransmitter that controls food intake, sleep, temperature regulation, pain control, sexual behaviors, and emotional regulation; it is implicated in anxiety, mood disorders, and schizophrenia.

3
New cards

Dopamine

An excitatory neurotransmitter that controls complex movements, motivation, and cognition, and regulates emotional responses; it is implicated in schizophrenia and movement disorders like Parkinson's.

4
New cards

Antipsychotics

Medications used to treat symptoms of psychosis such as delusions and hallucinations in schizophrenia and the manic phase of bipolar disorder.

5
New cards

SSRIs

The first choice in treating depression, PTSD, and OCD; they typically take 4 weeks for effect and should not be taken with St. Johns Wort.

6
New cards

TCAs (Tricyclic Antidepressants)

Used for MDD, anxiety, and insomnia; they are cardiotoxic, lethal in overdose, and have anticholinergic effects, taking 4-6 weeks for full effect.

7
New cards

MAOIs (Monoamine Oxidase Inhibitors)

Used for atypical or treatment-resistant depression; patients must avoid foods with tyramine to prevent a hypertensive crisis.

8
New cards

Tyramine-containing foods

Foods to avoid with MAOIs including mature or aged cheese, meats, yogurt, sour cream, peanuts, brewers yeast, banana peel, and avocado.

9
New cards

Neuroleptic Malignant Syndrome (NMS)

A life-threatening reaction to antipsychotics characterized by muscle rigidity, high fever, autonomic instability (unstable BP, diaphoresis, pallor), and delirium.

10
New cards

Metabolic Syndrome

A cluster of conditions associated with atypical antipsychotics that increase the risk for heart disease and diabetes, including weight gain, hypertension, high blood sugar, and high cholesterol.

11
New cards

Aksthisia

A type of Extrapyramidal Symptom (EPS) characterized by internal restlessness.

12
New cards

Dystonia

Severe muscle spasms that often start with the eyes and progress down the body.

13
New cards

Tardive dyskinesia

An irreversible condition characterized by lip smacking, tongue rolling, pill rolling, truncal twisting, and pelvic rocking.

14
New cards

Pseudoparkinsonism

A side effect presenting with a mask-like face, shuffling gait, cogwheel rigidity (ratchet-like joint movements), tremor, and drooling.

15
New cards

Anticholinergic Crisis

A life-threatening toxicity characterized by hyperthermia, delirium, mydriasis, flushed skin, and hallucinations; treated with the antidote physostigmine.

16
New cards

Competence

The ability of a patient to understand information, make a decision, and communicate that decision.

17
New cards

Involuntary Admission (1013)

An admission that lasts 7272 hours without the patient signing; if extended, it moves to a 1014 (55 days) and then a 1021 (court date).

18
New cards

Duty to Warn

A legal obligation for mental health professionals to protect identifiable persons if a patient makes a credible threat against them.

19
New cards

Psychiatric Advance Directives

A legal document completed by a competent individual stating their preferences for future psychiatric treatment during a potential mental health crisis.

20
New cards

Seclusion and Restraint Protocol

Requires a 1:1 evaluation within 11 hour, physician orders every 44 hours, and nurse documentation every 121-2 hours.

21
New cards

Triggering Phase

The stage of aggression where an environmental event initiates a response characterized by restlessness, pacing, and anxiety.

22
New cards

Escalation Phase

The stage of aggression where behaviors move toward a loss of control, involving yelling, swearing, and clenched fists.

23
New cards

Crisis Phase

The stage of aggression where the client loses control and may hit, kick, or throw objects; seclusion or restraints are used as a last resort.

24
New cards

Recovery Phase

The stage where the client regains physical and emotional control and is encouraged to talk about triggers.

25
New cards

Postcrisis Phase

The stage where the client attempts reconciliation and returns to prior functioning; often involves remorse or crying.

26
New cards

Cycle of Abuse

A repeating pattern in domestic violence consisting of the tension-building phase, the acute/explosion phase, and the honeymoon phase.

27
New cards

Shaken Baby Syndrome

A medical emergency involving whip-lash like head and neck injuries in infants, leading to retinal bleeding, bulging panels, and intracranial hemorrhage.

28
New cards

Factitious disorder (Munchausen’s Syndrome)

Injuries or illnesses in a child that are induced or fabricated by a caregiver to meet the caregiver's need for positive reinforcement.

29
New cards

Lethality Assessment

A series of questions to determine the risk of fatal violence, such as asking if the victim feels safe or if the perpetrator owns guns.

30
New cards

Safety Plan (Go Bag)

A prepared pack of essentials (ID, money, medication) and a strategy for safe shelter used by victims planning to leave an abusive environment.

31
New cards

PTSD (Posttraumatic Stress Disorder)

A pattern of behavior following a traumatic event involving reexperiencing the trauma, avoidance of reminders, negative cognitions, and hyperarousal.

32
New cards

Dissociative Fugue

A type of amnesia where the client suddenly moves to a new location, assumes a new identity, and has no memory of past events.

33
New cards

Secondary PTSD

A condition developed by individuals, such as nurses, who are indirectly exposed to trauma by caring for or witnessing the suffering of others.

34
New cards

Lithium

A first-line mood stabilizer for bipolar disorder with a therapeutic blood level of 0.51.50.5-1.5; requires monitoring of salt intake.

35
New cards

Valproic acid

A mood stabilizer that increases GABA to treat bipolar disorder and seizures; requires blood level monitoring and pregnancy tests for female patients.

36
New cards

Buspirone

An anxiolytic used for generalized anxiety disorder that takes 262-6 weeks for effect and carries no risk of sedation or dependence.

37
New cards

Beta-Blockers

Medications like Atenolol or Propranolol used for performance anxiety, which may cause side effects like bradycardia or hypotension.